Porton Pharma Solutions Ltd. (300363.SZ)
CNY 15.02
(0.74%)
CNY 15.02
(0.74%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 717.07 Million CNY | -20.52% |
| 2022 | 902.19 Million CNY | 19.12% |
| 2021 | 757.38 Million CNY | 76.33% |
| 2020 | 429.53 Million CNY | 25.27% |
| 2019 | 342.87 Million CNY | 27.16% |
| 2018 | 269.64 Million CNY | -0.09% |
| 2017 | 269.89 Million CNY | -7.62% |
| 2016 | 292.16 Million CNY | 3.84% |
| 2015 | 281.37 Million CNY | 84.88% |
| 2014 | 152.18 Million CNY | -19.25% |
| 2013 | 188.47 Million CNY | 43.58% |
| 2012 | 131.26 Million CNY | 33.43% |
| 2011 | 98.37 Million CNY | 26.59% |
| 2010 | 77.71 Million CNY | 40.37% |
| 2009 | 55.35 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 780.71 Million CNY | 16.31% |
| 2024 Q1 | 671.21 Million CNY | -6.4% |
| 2024 Q3 | 809.37 Million CNY | 3.67% |
| 2023 Q4 | 717.07 Million CNY | 18.53% |
| 2023 FY | 717.07 Million CNY | -20.52% |
| 2023 Q3 | 604.94 Million CNY | 7.19% |
| 2023 Q2 | 564.38 Million CNY | -17.54% |
| 2023 Q1 | 684.39 Million CNY | -24.14% |
| 2022 Q2 | 1.08 Billion CNY | 10.33% |
| 2022 Q1 | 981.1 Million CNY | 29.54% |
| 2022 FY | 902.19 Million CNY | 19.12% |
| 2022 Q4 | 902.19 Million CNY | -16.38% |
| 2022 Q3 | 1.07 Billion CNY | -0.32% |
| 2021 Q3 | 626.69 Million CNY | 29.61% |
| 2021 Q1 | 465.39 Million CNY | 8.35% |
| 2021 FY | 757.38 Million CNY | 76.33% |
| 2021 Q4 | 757.38 Million CNY | 20.85% |
| 2021 Q2 | 483.53 Million CNY | 3.9% |
| 2020 Q2 | 392.71 Million CNY | 3.8% |
| 2020 FY | 429.53 Million CNY | 25.27% |
| 2020 Q4 | 429.53 Million CNY | 6.08% |
| 2020 Q3 | 404.9 Million CNY | 3.1% |
| 2020 Q1 | 378.34 Million CNY | 10.35% |
| 2019 Q1 | 323.57 Million CNY | 20.0% |
| 2019 Q3 | 369.59 Million CNY | -1.92% |
| 2019 FY | 342.87 Million CNY | 27.16% |
| 2019 Q4 | 342.87 Million CNY | -7.23% |
| 2019 Q2 | 376.81 Million CNY | 16.46% |
| 2018 Q4 | 269.64 Million CNY | -6.86% |
| 2018 Q3 | 289.51 Million CNY | -6.88% |
| 2018 Q2 | 310.89 Million CNY | 9.26% |
| 2018 Q1 | 284.55 Million CNY | 5.43% |
| 2018 FY | 269.64 Million CNY | -0.09% |
| 2017 Q2 | 291.53 Million CNY | 10.29% |
| 2017 Q1 | 264.33 Million CNY | -9.53% |
| 2017 FY | 269.89 Million CNY | -7.62% |
| 2017 Q4 | 269.89 Million CNY | -17.91% |
| 2017 Q3 | 328.77 Million CNY | 12.78% |
| 2016 Q1 | 322.1 Million CNY | 14.48% |
| 2016 Q2 | 325.85 Million CNY | 1.17% |
| 2016 Q3 | 337.48 Million CNY | 3.57% |
| 2016 FY | 292.16 Million CNY | 3.84% |
| 2016 Q4 | 292.16 Million CNY | -13.43% |
| 2015 FY | 281.37 Million CNY | 84.88% |
| 2015 Q4 | 281.37 Million CNY | 12.38% |
| 2015 Q3 | 250.37 Million CNY | 48.6% |
| 2015 Q2 | 168.49 Million CNY | 14.59% |
| 2015 Q1 | 147.03 Million CNY | -3.38% |
| 2014 Q4 | 152.18 Million CNY | -17.21% |
| 2014 Q3 | 183.83 Million CNY | 13.7% |
| 2014 FY | 152.18 Million CNY | -19.25% |
| 2014 Q2 | 161.67 Million CNY | -2.43% |
| 2014 Q1 | 165.71 Million CNY | -12.07% |
| 2013 FY | 188.47 Million CNY | 43.58% |
| 2013 Q4 | 188.47 Million CNY | 0.0% |
| 2013 Q2 | 141.93 Million CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 FY | 131.26 Million CNY | 33.43% |
| 2011 FY | 98.37 Million CNY | 26.59% |
| 2010 FY | 77.71 Million CNY | 40.37% |
| 2009 FY | 55.35 Million CNY | 0.0% |